Results 201 to 210 of about 268,242 (398)

Interpretable machine learning enables early and accurate detection of drug‐induced liver injury: A multicenter study with real‐world clinical translation

open access: yesInterdisciplinary Medicine, EarlyView.
This study develops an interpretable gradient‐boosting model that accurately identifies drug‐induced liver injury (DILI) using routine laboratory data. The model explains key clinical features through SHapley Additive exPlanations analysis and detects DILI earlier than expert evaluation, offering a transparent and practical tool for precision ...
Jingyi Ling   +13 more
wiley   +1 more source

A Preliminary Exploratory Study on the Application of Gd-EOB-DTPA-Enhanced MRI for Assessing Gallbladder Ejection Fraction in Cholecystolithiasis Patients. [PDF]

open access: yesCan J Gastroenterol Hepatol
Zhang R   +13 more
europepmc   +1 more source

Microwave application to cholangioscopic treatment of diseases in the bile duct

open access: bronze, 2012
Shigeaki Ino-u-e   +6 more
openalex   +2 more sources

The changing face of hepatic resection [PDF]

open access: yes, 1989
Iwatsuki, S, Sheahan, DG, Starzl, TE
core   +1 more source

Virtual Magnetic Resonance Elastography Using a Deep Generative Model for Liver Fibrosis Staging

open access: yesiRADIOLOGY, EarlyView.
The proposed Registration‐based Generative Adversarial Network‐Convolutional Block Attention Module (RegGAN‐CBAM) model efficiently and reliably generates virtual MR elastography using diffusion weighted imaging. Strong correlation between virtual and native MR elastography for liver stiffness and viscosity are observed.
Longyu Sun   +9 more
wiley   +1 more source

Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S‐1 for Resectable Biliary Tract Cancer With FDG‐PET‐Positive Lymph Node Metastasis (KHBO1201): A Multicenter Phase II Trial

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Purpose To evaluate the safety and efficacy of neoadjuvant gemcitabine, cisplatin, and S‐1 (GCS) chemotherapy for resectable biliary tract cancer (BTC) and FDG‐PET‐positive lymph nodes in a multicenter phase II study (KHBO1201). Methods Patients with resectable BTC (intrahepatic/extrahepatic bile duct, gallbladder, or ampullary cancers) and ...
Satoshi Ogiso   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy